189 results
DEFA14A
AUPH
Aurinia Pharmaceuticals Inc
4 Jun 24
Additional proxy soliciting materials
5:25pm
that the forward-looking information will prove to be accurate. Forward-looking information by their nature are based on assumptions and involve known
8-K
EX-99.1
AUPH
Aurinia Pharmaceuticals Inc
2 May 24
Aurinia Pharmaceuticals Reports First Quarter 2024 Financial and Operational Results
6:03am
, there can be no assurance that the forward-looking information will prove to be accurate.
Forward-looking information by their nature are based
8-K
EX-99.1
ywksr605bwjmoqgn
15 Feb 24
Aurinia Discloses 2023 Year-End Financial and Operational Results, Announces Corporate Actions Focused on Enhancing Shareholder Value
6:06am
8-K
EX-99.1
jttv9zcd
5 Jan 24
Aurinia Provides Preliminary Unaudited Fourth Quarter and Full-year 2023 Net Revenue Results
6:02am
8-K
EX-99.1
no05zji
2 Nov 23
Aurinia Pharmaceuticals Reports Third Quarter and Nine Months 2023 Financial and Operational Results
6:01am
8-K
EX-10.1
tpyza
21 Sep 23
Aurinia Board of Directors Appoints Dr. Robert T. Foster as New Board Director
4:06pm
8-K
EX-99.1
plqt7hzn23c95i
3 Aug 23
Aurinia Pharmaceuticals Reports Second Quarter and Six Months 2023 Financial and Operational Results
6:03am
8-K
EX-99.1
wobgkz fxyeyhn8s
3 Jul 23
Aurinia Board of Directors Announces Exploration of Strategic Alternatives to Maximize Shareholder Value
6:06am
8-K
EX-99.1
fj1p7rl32c ib
4 May 23
Aurinia Pharmaceuticals Reports First Quarter 2023 Financial and Operational Results
6:06am